In HCC, the nuclear factor (erythroid-derived 2)-like 2 (NRF2)–kelch-like ECH-associated protein 1 (KEAP1) pathway is altered in 19% of cases, with 5% of these involving significantly altered genes [52]. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.